Slow Myopia Progression With Different Irradiance Light

Launched by BEIJING AIRDOC TECHNOLOGY CO., LTD. · May 21, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help slow down the progression of myopia, commonly known as nearsightedness, in children aged 6 to 12. The trial involves 75 children who will wear special glasses designed to expose their eyes to different levels of red light over a period of six months. The researchers want to find out whether using a higher or lower level of red light can better help manage myopia in children, and they will compare the results to see which group has the best outcomes.

To participate, children need to be between 6 and 12 years old and have a certain level of nearsightedness (between -0.50 D and -5.00 D). They should also be able to see well with glasses (vision of 0.8 or better). However, children with certain eye conditions, allergies to specific eye drops, or those already using other myopia control treatments won't be able to join. If your child is eligible and takes part, they will wear the glasses and have regular check-ups to monitor their eye health and vision over the six months. This study aims to find a safe and effective way to help children with myopia see better and reduce the chances of their condition worsening.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 6\~12 years old
• • Refractive Error of Myopia within -0.50 D\~-5.00 D, Anisometropia less or equal to 2.00D, The best corrected vision acuity is better or equal to 0.8 （decimal record).
• • Written consent formed with supervisions and children with 6 month follow-up.
• Exclusion Criteria:
• • Photophobia or allergy to any cycloplegic eyedrops (such as tropcaine, cyclopentolate).
• • Lesions in fundus or any part of eyeball with abnormal corrected vision such as keratoconus.
• • Strabisumus with angles large or equal to 5 prism dioper.
• • With other myopia control device such as atropine, Orthokeratology, Misight lens or other myopia control device.